CEA-, Her2/neu-, BCRP- and Hsp27-positive microparticles in breast cancer patients

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1707-1712

  Liebhardt, Susanne ^a   Ditsch, Nina ^a   Nieuwland, Rienk ^b   Rank, Andreas ^a   Jeschke, Udo ^a   Von Koch, Franz ^c   Friese, Klaus ^a   Toth, Bettina ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Klinikum Oritter Orden   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

BCRP; CEA; Her2 neu; HSP27; Microparticles

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEAT SHOCK PROTEIN 27; LIPOCORTIN 5; UNCLASSIFIED DRUG;

ADULT; BENIGN TUMOR; BREAST CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPH NODE METASTASIS; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A5; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2;

EID: 77954576916     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Seregni E, Coli A and Mazzucca N: Circulating tumour markers in breast cancer. Eur J Nucl Med Mol Imaging 31 (Suppl 1): S15-22, 2004.
2. Engel J et al: The process of metastasisation for breast cancer. Eur J Cancer 39(12): 1794-1806, 2003.
3. Look MP et al: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94(2): 116-128, 2002.
4. Braun S et al: A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353(8): 793-802, 2005. (Pubitemid 41215488)
5. Tesselaar ME et al: Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5(3): 520-527, 2007.
6. Toth B et al: Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 100(4): 663-669, 2008.
7. Toth B et al: Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res 28(2A): 1107-1112, 2008.
8. VanWijk MJ et al: Microparticles in cardiovascular diseases. Cardiovasc Res 59(2): 277-287, 2003.
9. Berckmans RJ et al: Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85(4): 639-646, 2001.
10. Martínez MC et al: Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 288: 1004-1009, 2005.
11. Kim CW et al: Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 62(21): 6312-6317, 2002.
12. Kanazawa S et al: Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39: 145-149, 2003. (Pubitemid 36173614)
13. Hron G et al: Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer. Cellular Proteolysis and Oncology, 2007.
14. Savasan S et al: Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms. J Clin Pathol 57(6): 651-653, 2004.
15. Falanga A, Barbui T and Rickles FR: Hypercoagulability and tissue factor gene up-regulation in hematologic malignancies. Semin Thromb Hemost 34(2): 204-210, 2008.
16. Helley D et al: Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol, 2008.
17. Egawa K et al: The carcinoembryonic antigen (CEA) family (CD66) expressed in melanocytic naevi is not expressed in blue naevuscell naevi in dendritic type. J Cutan Pathol 27(7): 351-358, 2000.
18. Stearns V, Yamauchi H and Hayes DF: Circulating tumor markers in breast cancer: accepted utilities and novel prospects. Breast Cancer Res Treat 52(1-3): 239-259, 1998. (Pubitemid 29056099)
19. Cheung KL, Graves CR and Robertson JF: Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26(2): 91-102, 2000. (Pubitemid 30182241)
20. Coussens L et al: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139, 1985. (Pubitemid 16169997)
21. Shih C et al: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-264, 1981. (Pubitemid 11149660)
22. Kaptain S, Tan LK and Chen B: Her-2/neu and Breast Cancer. Diagnost Mol Pathol 10(3): 139-152, 2001.
23. Pauletti G et al: Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996. (Pubitemid 26248546)
24. Slamon DJ et al: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
25. Perez-Tomas R: Multidrug resistance: retrospect and prospects in anticancer drug treatment. Curr Med Chem 13(16): 1859-1876, 2006.
26. Ishikawa T et al: Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells. Curr Pharm Des 12(3): 313-325, 2006.
27. Ejendal KF and Hrycyna CA: Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr Protein Pept Sci 3(5): 503-511, 2002.
28. Concannon CG, Gorman AM and Samali A: On the role of Hsp27 in regulating apoptosis. Apoptosis 8(1): 61-70, 2003.
29. Arrigo AP et al: Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett 581(19): 3665-3674, 2007.
30. Nieuwland R et al: Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96(10): 3534-3541, 1997. (Pubitemid 27513430)
31. Gilbey AM et al: The detection of circulating breast cancer cells in blood. J Clin Pathol 57(9): 903-911, 2004.